期刊文献+

糖尿病肾病与氧化应激 被引量:36

下载PDF
导出
摘要 糖尿病肾病(DN)是糖尿病(DM)患者主要微血管并发症之一,随着DM发病率逐年上升,DN已成为在全世界范围内终末期。肾病的主要原因之一,同时也是DM患者生活质量下降和病死率增高的主要原因之一。DN的基本病理改变是肾小球基底膜增厚、系膜基质增生和细胞外基质(ECM)重构,功能上主要表现为高滤过、高灌注以及肾小球滤过屏障改变,
出处 《中国老年学杂志》 CAS CSCD 北大核心 2013年第5期1237-1239,共3页 Chinese Journal of Gerontology
  • 相关文献

参考文献22

  • 1Hakim FA,Pflueger A.Role of oxidative stress in diabetic kidney disease〔J〕.Med Sci Monit,2010;16(2):A37-48.
  • 2Kiyomoto H,Rafiq K,Mostofa M,et al.Possible underlying mechanismsresponsible for aldosterone and mineralocorticoid receptor-dependent re-nal injury〔J〕.J Pharmacol Sci,2008;108(4):399-405.
  • 3Singh DK,Winocour P,Farrington K.Oxidative stress in early diabeticnephropathy:fueling the fire〔J〕.Nat Rev Endocrinol,2011;7(3):176-84.
  • 4Bhor VM,Raghuram N,Sivakami S.Oxidative damage and altered antiox-idant enzyme activities in the small intestine of streptozotocin-induced di-abetic rats〔J〕.Int J Biochem Cell Biol,2004;36(1):89-97.
  • 5韩宝玲.氧化应激在2型糖尿病及其并发症发病机制中的作用[J].实用临床医药杂志,2011,15(3):122-124. 被引量:33
  • 6Fukami K,Ueda S,Yamagishi S,et al.AGEs activate mesangial TGF-be-ta-Smad signaling via an angiotensin II type I receptor interaction〔J〕.Kidney Int,2004;66(6):2137-47.
  • 7: PMrabhakar S,Starnes J,Shi S,et al.Diabetic nephropathy is associatedwith oxidative stress and decreased renal nitric oxide production〔J〕.JAm Soc Nephrol,2007;18(11):2945-52.
  • 8Wolf G,Chen S,Ziyadeh FN.From the periphery of the glomerular capil-lary wall toward the center of disease:podocyte injury comes of age in di-abetic nephropathy〔J〕.Diabetes,2005;54(6):1626-34.
  • 9Brezniceanu ML,Liu F,Wei CC,et al.Attenuation of interstitial fibrosisand tubular apoptosis in db/db transgenic mice overexpressing catalase inrenal proximal tubular cells〔J〕.Diabetes,2008;57(2):451-9.
  • 10朱斌,沈汉超.糖尿病氧化应激的研究进展及其与糖尿病肾病的关系[J].国外医学(泌尿系统分册),2004,24(6):818-822. 被引量:18

二级参考文献95

  • 1邹丽霞,谷卫.环氧化酶-2与糖尿病[J].国际内分泌代谢杂志,2006,26(1):45-47. 被引量:11
  • 2梁丽,李成江.2型糖尿病的抗氧化剂治疗[J].国外医学(老年医学分册),2006,27(3):133-136. 被引量:4
  • 3常洁,姜宗培,余学清.氧化应激及其在糖尿病肾病中的作用[J].国际内科学杂志,2007,34(2):105-108. 被引量:25
  • 4Smith A R, Shenvi S V. Widlansky M, et al. Lipoic acid as a potential therapy for chronic diseases associated with oxida-tive stress[J]. Curr Med Chem, 2004, 11(9): 1135.
  • 5Ruhnau K J, Meissner H P, Firm J R, et al. Effects of 3 - week oral treatment with the antioxidant thioctic acid (alpha - lipoic acid) in symptomatic diabetic polyneuropathy [ J ]. Diabet Med, 1999, 16(12): 1040.
  • 6Cam M, Yavuz O, Guven F, et al. Protective effeets of chronic melatonin treatmenr against renal injury in streptozo- tocin- induced diabetic rats[J]. J Pineal Res, 2003, 35(3) : 212.
  • 7Baydas G, Reirer R J, YaserA, et al. Melatonin reduces glial reactivity in the hippocarnpus, cortex, and cerebellum of streptozotocin- induced diabetic rats [ J ]. Free Radic Biol Med, 2003, 35(7): 797.
  • 8Martinon F, Petrilli V, Mayor A, et al. Gout associated uric acid crystals activate the NALP3 inflammasome[ J ]. Nature, 2006, 440(7081) : 237.
  • 9Lau A K, Leichtweis S B, Hume P, et al. Probucol pro- motes functional reendothelialization in balloon- iniured rab- bit aortas[J]. Circulation, 2003, 107(15): 2031.
  • 10Penckofer S, Schwerm D, Florzak K. Oxidative stress and cardiovascular disease in type 2 diabets: the role of antioxidams and prcoxidants[J]. J Cardiovasc Nuts, 2002, 16(2) : 68.

共引文献80

同被引文献478

引证文献36

二级引证文献328

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部